BIOMARIN PHARMACEUTICAL INC - Director's Dealing 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2014-05-30

Reporting Person: Davis George Eric (SVP, General Counsel)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-05-30	Common Stock	G	180	$23.21	Disposed	56588	Direct
2014-06-03	Common Stock	D	3562	$60.00	Disposed	53026	Direct
2014-06-04	Common Stock	A	11400	—	Acquired	64426	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-06-04	Stock Option (right to buy) Common Stock	$63.10	A	42700	Acquired	2024-06-03	Common Stock (42700)	Direct

F1: Transaction made pusuant to a Rule 10b5-1 trading place executed on December 11, 2013.

F2: All shares sold at same price.

F3: Restricted stock units granted on June 4, 2014. Price not applicable.

F4: Option grant vests 6/4ths on December 4, 2014 and 1/48th on the 4th da of every month thereafter